Selection of blockbuster announcements
1. Xiansheng Pharmaceutical Co., Ltd.: all patients were enrolled in the II/III phase clinical study of anti-novel coronavirus candidate innovative drug SIM0417.
$SIMCERE PHARMA (02096.HK)$Announcement, December 16, 2022 Significant progress has been made in anti-novel coronavirus candidate TM (SIM0417) in cooperation with Shanghai Institute of Medicine and Wuhan Institute of virus, Chinese Academy of Sciences: a multicenter, randomized, double-blind, multicenter, randomized, double-blind, multicenter, randomized, double-blind evaluation of the efficacy and safety of Xenoxin TM in the treatment of mild to moderate COVID-19 adult infections. A placebo-controlled phase II/III clinical trial has been completed. All 1208 patients enrolled in the group will accelerate the analysis of clinical research results. Is actively preparing applications for new drugs to be put on the market.
2. Shisi Pharmaceutical Group signed a letter of intent with a famous domestic pharmaceutical company to commission the production of ibuprofen sustained-release tablets.
$SSY GROUP (02005.HK)$According to the announcement, Shijiazhuang four Pharmaceutical Co., Ltd., a wholly owned subsidiary of the group, signed a letter of intent with a famous domestic pharmaceutical company on December 17, 2022. According to the letter of intent, the entrusting party intends to entrust Shijiazhuang four drugs to produce ibuprofen sustained-release tablets and children's paracetamol Huang Namin granules, with an annual production capacity of 1 billion to 2.5 billion tablets and 65 million bags per year, respectively.
3. Six gaming companies, including Sands China Ltd. and Wynn Macau, have been awarded
$WYNN MACAU (01128.HK)$According to the announcement, on December 16, 2022, WRM, a wholly-owned subsidiary of the company, was officially awarded the betting award for operating lucky betting in casinos in Macau under the final betting contract signed with the Macau government, and WRM was granted a 10-year betting grant.$SANDS CHINA LTD (01928.HK)$In an announcement, following the completion of the VML capital change on 7 December 2022, through the approval of the Chief Executive of Macau, China and under the gaming operation contract entered into with Macau, China on 16 December 2022, VML, a subsidiary of the Company, was awarded to the gaming operator of Lucky Gaming, which operates a casino in Macau, China. Besides. Include$SJM HOLDINGS (00880.HK)$、$MELCO INT'L DEV (00200.HK)$、$MGM CHINA (02282.HK)$、$GALAXY ENT (00027.HK)$Several betting stocks have also been granted.
4. China Railway Construction Corporation introduces four major banks to carry out 10 billion debt-to-equity swaps.
$CHINA RAIL CONS (01186.HK)$Signed an agreement with Bank of China assets, Jianxin Investment, ICBC Investment and BoCom Investment to attract a total of 10 billion yuan for the 14th Bureau of China Railway, the 18th Bureau of China Railway, the 20th Bureau of China Railway and the urban construction of China Railway by carrying out debt-to-equity business.
5. China Resources Power Holdings: cumulative electricity sales of affiliated power plants in the first 11 months increased by 3.9% year on year to 166 million megawatt hours.
$CHINA RES POWER (00836.HK)$According to the announcement, the cumulative electricity sales of affiliated power plants reached 166 million megawatts in the first 11 months of 2022, an increase of 3.9 percent over the same period last year. Among them, the cumulative electricity sales of affiliated wind farms reached 31.7186 million megawatt hours, an increase of 10.5 percent over the same period last year. The cumulative electricity sales of affiliated photovoltaic power stations reached 1.2439 million megawatt hours, an increase of 18.2 percent over the same period last year.
6. Datang New Energy: the output of 2.694 million MW hours in November increased by 6.85% over the same period last year, of which photovoltaic power generation increased by 45%.
$DATANG RENEW (01798.HK)$Electricity production in November was 2.6941 million megawatt hours, up 6.85 per cent from a year earlier. Of this total, wind power was 2.5555 million megawatt hours, up 5.34 percent from the same period last year; photovoltaic power generation was 138600 megawatt hours, up 45.51 percent from the same period last year.
7. Boan Bio-B plans to issue 10.6948 million shares from December 19 to 22.
$BOAN BIOTECH-B (06955.HK)$It is announced that the company intends to issue 10.6948 million H shares at 09:00-22 noon on December 19, 2022, of which 1.0696 million shares will be offered in Hong Kong and 9.6252 million shares will be offered internationally (including 534800 reserved shares under the preferred offering, it is redistributable and subject to the exercise of the over-allotment option), with a 15% over-allotment option at an issue price of HK $19.80 per H share, 200 shares per share. Trading in H shares is expected to commence on the main board of the Stock Exchange at 09:00 on December 30, 2022.
Important matters
Us East Motor (01268) will pay an interim dividend of HK $0.09005 per share on December 28th.
Beijing Water Control Group (00371) received a loan of HK $4 billion
News of new shares
Boan Bio-B plans to issue 10.6948 million shares from December 19 to 22.
TECHSTARACQ-Z (07855) proposes to issue 100.1 million Class A shares and 50.05 million listed warrants at an issue price of HK $10 per Class A share.
Tehai International (09658) is expected to start trading on the main board of the Stock Exchange by introduction.
Operation data
The total sales income of R & F Real Estate (02777) in the first 11 months is about 36.39 billion yuan.
Guohao Group (00053): similar net gaming revenue of Rank Group rose 1% in May compared with the same period last year.
Electricity sales of China Resources Power Holdings (00836) affiliated power plant increased by 3.9% in the first 11 months.
Datang New Energy (01798): 2.694 million MW hours of electricity generated in November increased by 6.85% compared with the same period last year
Additional rights issue
Hop King Pacific Group (01813) plans to place 235 million shares first and then new to raise a net HK $467 million
Yao Ming Juno-B (02126) Grant share options and restricted share Units
Merger and acquisition and sale
South China City (01668) subsidiary plans to sell about 69.35% of the shares in Xi'an South China City for 5 billion yuan.
Shandong Gold Mining (01787) intends to acquire 80% equity and 100% creditor's rights in Laizhou Jinan.
China Shenhua Energy (01088): bid for 30% stake in Jinjie Energy held by Capital Weiye
Investment and operation
Six gaming companies, including Sands China Ltd. and Wynn Macau, have been awarded
Galaxy Entertainment (00027): Galaxy Casino is approved to operate 1000 entertainment tables and 1700 gaming machines
SJM Holdings (00880): SJM is authorized to operate 1250 gaming tables and 1700 gaming machines
Fosun (00656): Fulang Holdings listed on the New York Stock Exchange
CNOOC Petrochemical (03983): the Stock Exchange granted listing approval for a number of unlisted H-shares in full circulation.
Shandong Gold Mining (01787) intends to use no more than 270 million yuan to raise idle funds to temporarily replenish the working capital.
China Petroleum & Chemical Corporation (00386): the transfer of state-owned shares is approved by the SASAC of the State Council.
Repurchase cancellation
Tencent (00700) spent HK $350 million to buy back 1.11 million shares on December 16.
AIA Group Limited (01299) spent HK $225 million to buy back 2.6584 million shares on December 16.
Great Wall Motor (02333) spent HK $114 million to buy back 10.806 million shares on December 16.
Pop Mart International (09992) spent HK $10.3696 million to buy back 550000 shares on December 16.
Haier Smart Home (06690) spent HK $8.5279 million to buy back 323600 shares on December 16.
DongFeng Motor Group (00489) spent HK $14.8957 million to buy back 3.25 million shares on December 16.
KE Holdings Inc.-W (02423) spent US $2 million to buy back 414000 shares on December 15.
Increase and decrease holdings
XPeng Inc.-W (09868) was awarded 8.4343 million shares by JPMorgan Chase & Co
Shandong Xinhua Pharmaceutical shares (00719) increased by 5.75 million shares by JPMorgan Chase & Co
China Molybdenum (03993) was reduced by 5.265 million shares by Blackrock
CANSINOBIO (06185) was awarded 528000 shares by JPMorgan Chase & Co
Edit / ruby